P 101
Alternative Names: P-101Latest Information Update: 23 Oct 2008
At a glance
- Originator Potomac Pharma
- Class Antipsychotics
- Mechanism of Action Alpha 2 adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Schizophrenia
Most Recent Events
- 09 Nov 2004 Phase-II clinical trials in Schizophrenia in USA (unspecified route)